STOCK TITAN

Chemed (NYSE: CHE) director sells 500 shares in open-market trade

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Chemed Corp director George J. Walsh III reported an open-market sale of company stock. He sold 500 shares of Chemed capital stock at a price of $437.83 per share. After this sale, he continues to hold 3,209 shares directly and 434 shares indirectly through his spouse.

Positive

  • None.

Negative

  • None.
Insider WALSH GEORGE J III
Role null
Sold 500 shs ($219K)
Type Security Shares Price Value
Sale Capital Stock 500 $437.83 $219K
holding Capital Stock -- -- --
Holdings After Transaction: Capital Stock — 3,209 shares (Direct, null); Capital Stock — 434 shares (Indirect, spouse)
Footnotes (1)
Shares sold 500 shares Open-market sale of Chemed capital stock
Sale price $437.83 per share Price for the 500-share open-market sale
Direct holdings after sale 3,209 shares Total Chemed capital stock held directly post-transaction
Indirect holdings (spouse) 434 shares Chemed capital stock held indirectly through spouse
Net share change -500 shares Net-sell position from reported transactions
open-market sale financial
"transaction_action: "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Capital Stock financial
"security_title: "Capital Stock""
Capital stock is the total set of shares that represent ownership in a company, including different classes such as common and preferred stock. Think of it as the number and types of slices in a company’s ownership pie: it matters to investors because it determines voting power, entitlement to dividends, and how a company’s value is divided per share, so changes in capital stock can dilute holdings or alter per‑share metrics.
indirect ownership financial
"ownership_type: "indirect" with nature_of_ownership: "spouse""
net-sell financial
"transactionSummary shows netBuySellDirection: "net-sell""
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
WALSH GEORGE J III

(Last)(First)(Middle)
2600 CHEMED CENTER
255 EAST 5TH STREET

(Street)
CINCINNATI OHIO 45202

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CHEMED CORP [ CHE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/29/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Capital Stock05/29/2026S500D$437.833,209D
Capital Stock434Ispouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
George J. Walsh III05/29/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Chemed (CHE) director George J. Walsh III report?

Chemed director George J. Walsh III reported an open-market sale of 500 shares of Chemed capital stock. The transaction was recorded as a sale at a specified share price, with updated post-transaction holdings disclosed in the filing for transparency.

At what price did the Chemed (CHE) director sell his shares?

The director sold 500 shares of Chemed capital stock at $437.83 per share. This per-share price comes directly from the reported open-market transaction details, which also list the number of shares sold and resulting ownership.

How many Chemed (CHE) shares does the director hold after this Form 4 sale?

After the reported sale, George J. Walsh III holds 3,209 shares of Chemed capital stock directly. The filing also shows indirect ownership of 434 shares through his spouse, providing a combined picture of his remaining reported equity exposure.

Does the Chemed (CHE) Form 4 include any indirect ownership by the director?

Yes. The Form 4 lists 434 shares of Chemed capital stock held indirectly through the director’s spouse. These are reported separately from his 3,209 directly held shares, clarifying the structure of his beneficial ownership in the company.

What is the net share change reported in this Chemed (CHE) insider filing?

The filing shows a net-sell position of 500 shares for the reporting period. This reflects the 500-share open-market sale, with no reported purchases or derivative exercises offsetting that disposition in the same Form 4 submission.